Skip Navigation

Cardiovascular Research 2003 60(2):355-364; doi:10.1016/j.cardiores.2003.08.001
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brunner, F.
Right arrow Articles by Wölkart, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunner, F.
Right arrow Articles by Wölkart, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Peroxynitrite-induced cardiac depression: role of myofilament desensitization and cGMP pathway

Friedrich Brunner* and Gerald Wölkart

Institut für Pharmakologie und Toxikologie, Karl-Franzens-Universität Graz, Universitätsplatz 2, A-8010 Graz, Austria

*Corresponding author. Tel.: +43-316-380-5559; fax: +43-316-380-9890. Email address: friedrich.brunner{at}kfunigraz.ac.at

Objective: The oxidant species peroxynitrite, the reaction product of nitric oxide (NO·) and superoxide, has been implicated in several pathophysiological conditions of the heart. Here, we studied the mechanism of peroxynitrite-induced cardiac depression using specific drugs and simultaneous analyses of myocardial function and intracellular Ca2+ ([Ca2+]i). Methods: Rat hearts were perfused retrogradely and left ventricular function (balloon method) and [Ca2+]i transients were recorded on a beat-to-beat basis using the aequorin bioluminescence method. Peroxynitrite was infused at 10.8±0.93 µM via sideline for 10 min, followed by a 15-min recovery period to monitor irreversible effects. Test drugs were infused prior to and during peroxynitrite application. Results: Peroxynitrite depressed left ventricular developed pressure (LVDevP; –40%), yet increased systolic and diastolic [Ca2+]i (1.3– and 2.3–fold, respectively; n = 12). When Ca2+ entry through Ca2+ channels or Na+/Ca2+ exchange transport was blocked using nicardipine (1 µM, n = 3) or dichlorobenzamil (30 µM, n = 5), respectively, cells showed lower [Ca2+]i and accentuated negative inotropic action in response to peroxynitrite. Peroxynitrite slowed left ventricular relaxation and [Ca2+]i transients, both of which were not affected by extracellular Ca2+ restriction. Importantly, the oxidant greatly depressed myofilament responsiveness to Ca2+, which was partly antagonized by Rp-8-(4-chlorophenylthio)guanosine-3',5'-cyclic monophosphorothioate (Rp-cGMPS), an inhibitor of cGMP-dependent protein kinase. Also, the inhibitor partially restored left ventricular contractility (n = 6). Peroxynitrite stimulated cardiac cGMP production and coronary cGMP efflux (n = 6). Decomposed peroxynitrite had no effect in any of the tests. Conclusions: Peroxynitrite depresses myocardial contractility by decreasing the ability of Ca2+ to trigger contraction, and this effect is partly mediated by the cGMP/cGMP-dependent protein kinase pathway.

KEYWORDS Peroxynitrite; Contractility; Free radicals; Calcium


Time for primary review 16 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
T. Dai, Y. Tian, C. G. Tocchetti, T. Katori, A. M. Murphy, D. A. Kass, N. Paolocci, and W. D. Gao
Nitroxyl increases force development in rat cardiac muscle
J. Physiol., May 1, 2007; 580(3): 951 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Pozo-Navas, H. Stessel, G. Wolkart, and F. Brunner
Role of Myocardial Nitric Oxide in Diabetic Ischemia-Reperfusion Dysfunction: Studies in Mice with Myocyte-Specific Overexpression of Endothelial Nitric-Oxide Synthase
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 729 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. S. Joshi, M. W. Julian, J. E. Huff, J. A. Bauer, Y. Xia, and E. D. Crouser
Calcineurin Regulates Myocardial Function during Acute Endotoxemia
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 999 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Paolocci
Peroxynitrite like Pan?
Cardiovasc Res, August 1, 2005; 67(2): 176 - 178.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Borbely, A. Toth, I. Edes, L. Virag, J. G. Papp, A. Varro, W. J. Paulus, J. van der Velden, G. J.M. Stienen, and Z. Papp
Peroxynitrite-induced {alpha}-actinin nitration and contractile alterations in isolated human myocardial cells
Cardiovasc Res, August 1, 2005; 67(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
X.-W. Yu, M.-Y. G Liu, R. H Kennedy, and S. J Liu
Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes
J. Physiol., July 15, 2005; 566(2): 341 - 353.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Layland, R. J. Solaro, and A. M. Shah
Regulation of cardiac contractile function by troponin I phosphorylation
Cardiovasc Res, April 1, 2005; 66(1): 12 - 21.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. J. Lokuta, N. A. Maertz, S. V. Meethal, K. T. Potter, T. J. Kamp, H. H. Valdivia, and R. A. Haworth
Increased Nitration of Sarcoplasmic Reticulum Ca2+-ATPase in Human Heart Failure
Circulation, March 1, 2005; 111(8): 988 - 995.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.